Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-123684
Filing Date
2024-11-08
Accepted
2024-11-08 07:17:27
Documents
87
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q flgt-20240930.htm   iXBRL 10-Q 2921305
2 EX-31.1 flgt-ex31_1.htm EX-31.1 14733
3 EX-31.2 flgt-ex31_2.htm EX-31.2 14860
4 EX-32.1 flgt-ex32_1.htm EX-32.1 16628
  Complete submission text file 0000950170-24-123684.txt   12745002

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT flgt-20240930.xsd EX-101.SCH 1446243
89 EXTRACTED XBRL INSTANCE DOCUMENT flgt-20240930_htm.xml XML 2862834
Mailing Address 4399 SANTA ANITA AVE EL MONTE CA 91731
Business Address 4399 SANTA ANITA AVE EL MONTE CA 91731 626-350-0537
Fulgent Genetics, Inc. (Filer) CIK: 0001674930 (see all company filings)

EIN.: 812621304 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37894 | Film No.: 241437993
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)